Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 47

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 47
---
 
 of $130.52 per share;                                                                                                              |
| · | 53,574 shares of common                                                                                                            
 stock issuable pursuant to outstanding restricted stock units;                                                                     |
| · | 319,518 shares of common                                                                                                           
 stock reserved for future issuance under our equity incentive plan; and                                                            |
| · | 2,129,187 shares of common                                                                                                         
 stock reserved for issuance upon the exercise of outstanding warrants at a weighted-average exercise price of $3.44 per share.     |

| 30 |

<div align='center'>DESCRIPTION OF CAPITAL STOCK</div>

The following description of
our capital stock is intended as a summary only and therefore is not a complete description of our capital stock. This description is
based upon, and is qualified in its entirety by reference to, our articles of incorporation, our bylaws and applicable provisions of
Nevada corporate law. You should read our articles of incorporation and bylaws, which have been publicly filed with the SEC, for the
provisions that are important to you.

Authorized Capital Stock

Our authorized capital consists
of 60,000,000 shares of common stock, par value $0.001 per share. As of September 3, 2025, there were 2,598,711
shares of common stock issued and outstanding.

Common Stock

The holders of our common stock
are entitled to one vote per share on all matters to be voted on by the stockholders. Holders of common stock are entitled to receive
ratably such dividends as may be declared by the Board of Directors out of funds legally available therefor. If we liquidate, dissolve
or wind up, holders of common stock are entitled to share ratably in all assets remaining after payment of all debts and other liabilities.
Holders of common stock have no preemptive, conversion or subscription rights. There are no redemption or sinking fund provisions applicable
to the common stock.

Our bylaws provide that stockholders
representing a majority of the voting power of our capital stock, represented in person or by proxy (regardless of whether the proxy
has authority to vote on all matters), are necessary to constitute a quorum for the transaction of business at any meeting, but at any
time during which shares of our capital stock are listed for trading on Nasdaq, stockholders representing not less than 33 1/3% of the
voting power of our capital stock, represented in person or by proxy (regardless of whether the proxy